InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.060
-0.040 (-3.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
InflaRx Employees
InflaRx had 74 employees as of December 31, 2024. The number of employees increased by 12 or 18.97% compared to the previous year.
Employees
74
Change (1Y)
12
Growth (1Y)
18.97%
Revenue / Employee
$996
Profits / Employee
-$635,850
Market Cap
71.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IFRX News
- 25 days ago - InflaRx N.V. (IFRX) Discusses Topline Phase 2a Data in Chronic Spontaneous Urticaria and Hidradenitis Suppurativa Transcript - Seeking Alpha
- 25 days ago - InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU) - GlobeNewsWire
- 4 weeks ago - InflaRx to Announce Topline Data from Phase 2a Clinical Trial of INF904 in Hidradenitis Suppurativa and Chronic Spontaneous Urticaria - GlobeNewsWire
- 6 weeks ago - InflaRx Announces Participation in the Guggenheim Securities 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 3 months ago - InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 3 months ago - InflaRx Announces Participation in September Investor Conferences - GlobeNewsWire
- 4 months ago - InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - InflaRx to Report Second Quarter 2025 Results on August 7, 2025 - GlobeNewsWire